<SEC-DOCUMENT>0001213900-25-067048.txt : 20250723
<SEC-HEADER>0001213900-25-067048.hdr.sgml : 20250723
<ACCEPTANCE-DATETIME>20250723172735
ACCESSION NUMBER:		0001213900-25-067048
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250723
DATE AS OF CHANGE:		20250723
EFFECTIVENESS DATE:		20250723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYENCE BIOMEDICAL LTD.
		CENTRAL INDEX KEY:			0001985062
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288905
		FILM NUMBER:		251143911

	BUSINESS ADDRESS:	
		STREET 1:		121 RICHMOND STREET WEST PENTHOUSE
		STREET 2:		SUITE 1300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 2K1
		BUSINESS PHONE:		27744604171

	MAIL ADDRESS:	
		STREET 1:		121 RICHMOND STREET WEST PENTHOUSE
		STREET 2:		SUITE 1300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 2K1
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0250018-s8_psyence.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><B>As filed with the Securities and
Exchange Commission on July 23, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Psyence Biomedical Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name ofregistrant as specified
in its charter)</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ontario, Canada</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction of <BR>
Incorporation or Organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer <BR>
Identification No.)</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>121 Richmond Street West <BR>
Penthouse Suite 1300 <BR>
Toronto, Ontario</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>M5H2Kl</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(Address of Principal Executive Offices)</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">(Zip Code)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 100%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Psyence Biomedical 2023 Equity Incentive Plan</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(Full Title of the Plan)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Puglisi </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&amp;</FONT>
<B>Associates<BR>
850 Library Ave., Suite 204<BR>
Newark, Delaware 19711</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name and address of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(302) 738-6680</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Telephone number, including area code, of agent
for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>With copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ari Edelman</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Edelman Legal Advisory PLLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>400 Rella Boulevard, Suite 165</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Suffern, New York 10901</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(845) 533-3435</B></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Indicate by check
mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or
an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller
reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Securities Exchange Act of 1934 (the &ldquo;Exchange
Act&rdquo;).</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Large accelerated filer</TD>
    <TD STYLE="width: 10%">&#9744;&nbsp;</TD>
    <TD STYLE="width: 40%">Accelerated filer</TD>
    <TD STYLE="width: 10%">&#9744;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Non-accelerated filer</TD>
    <TD>&#9746;&nbsp;</TD>
    <TD>Smaller reporting company</TD>
    <TD>&#9746;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Emerging growth company</TD>
    <TD>&#9746;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Registration Statement on Form S-8 (the &ldquo;Registration Statement&rdquo;)
is filed in accordance with General Instruction E to Form S-8 under the Securities Act of 1933 to register an additional 70,174 shares
of common stock of Psyence Biomedical Ltd. (the &ldquo;Registrant&rdquo;) reserved under the Psyence Biomedical Ltd 2023 Equity Incentive
Plan (as amended, the &ldquo;Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Registration Statement incorporates by reference the Registration
Statement on Form S-8 (Commission File No. 333-281112) originally filed on July 31, 2024, covering the initial 3,360 shares reserved under
the Plan, to the extent not superseded hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION
lO(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Item 1. Plan Information.*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Item 2. Registration Information and Employee Plan Annual
Information.*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The documents containing the information specified in Item 1
and Item 2 of Part I of Form S-8 (Plan Information and Registration Information and Employee Plan Annual Information) will be sent or
given to recipients of the grants under the Plan as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules
and regulations of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) and the instructions to Form S-8, such documents
are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant
to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant
to Item 3 of Part II hereof, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
The Registrant will provide a written statement to participants advising them of the availability without charge, upon written or oral
request, of the documents incorporated by reference in Item 3 of Part II hereof and including the statement in the preceding sentence.
The written statement to all participants will indicate the availability without charge, upon written or oral request, of other documents
required to be delivered pursuant to Rule 428(b) of the Securities Act, and will include the address and telephone number to which the
request is to be directed.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Item 3. Incorporation of Documents by Reference.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Registrant
is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). The
Commission maintains a website that contains reports, proxy and information statements and other information regarding registrants that
file electronically with the Commission, including the Registrant. The address for the Commission&rsquo;s website is &ldquo;http://www.sec.gov.&rdquo;
The following documents filed by the Registrant with the Commission are incorporated herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.</FONT></TD><TD STYLE="text-align: justify">Our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025057893/ea0246623-20f_psyence.htm">Form 20-F</A> which was filed with the Commission
on June 25, 2025 (the &ldquo;Annual Report&rdquo;) for the fiscal year ended March 31, 2025;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">The description of our Common Stock filed as <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000141057824001112/pbm-20240331xex2d3.htm">Exhibit 2.4</A> to
the Annual Report;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">The Current Reports on Form 6-K filed on the following dates:
<A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025027251/ea0236551-6k_psyence.htm">April 1, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025031060/ea0237635-6k_psyence.htm">April 11, 2025</A> (other than exhibit 99.3), <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025034643/ea0239303-6k_psyence.htm">April 23, 2025</A> (other than exhibits 99.2 and 99.3) <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025053433/ea0245269-6k_psyence.htm">June 11, 2025</A> (other than
exhibit 99.2), <A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025057779/ea0246906-6k_psyence.htm">June 25, 2025</A> (other than exhibits 99.2 and 99.3); and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">All other reports filed pursuant to Section&nbsp;13(a) or 15(d)
of the Exchange Act since the end of the fiscal year covered by the Annual Report referred to in (a)&nbsp;above.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Except to the
extent such information is deemed furnished and not filed pursuant to securities laws and regulations, all documents that we file with
the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, in each case, subsequent to the date of this Registration
Statement and prior to the filing of a post-effective amendment to this Registration Statement (that indicates that all securities offered
under this Registration Statement have been sold or that deregisters all securities then remaining unsold) shall be deemed to be incorporated
by reference in this Registration Statement and to be part hereof from the date of filing of such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Any statement
contained herein or in a document all or a portion of which is incorporated or deemed to be incorporated by reference herein shall be
deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in
any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Item 8. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt">The following exhibits are filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: justify"><B>Exhibit<BR>
Number</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><B>Description of Exhibit</B></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify">4.1</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000110465923117179/tm2320950-15_f4a.htm#tANNB1">Certificate of Incorporation of Psyence Biomedical Ltd. (incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Registration Statement on Form F-4 (File No. 333-273553) filed with the SEC on November 13, 2023).</A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify">4.2</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000110465923117179/tm2320950-15_f4a.htm#tANNXC">Amended and Restated Bylaws of Psyence Biomedical&nbsp;Ltd. (incorporated by reference to Exhibit&nbsp;3.3 to the Company&rsquo;s Registration Statement on Form&nbsp;F-4 (File No.&nbsp;333-273553) filed with the SEC on November&nbsp;13, 2023).</A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify">5.1*</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="ea025001801ex5-1_psyence.htm">Opinion of WeirFoulds LLP.</A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify">23.1*</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="ea025001801ex23-1_psyence.htm">Consent of MNP LLP.</A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify">23.2*</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="ea025001801ex5-1_psyence.htm">Consent of WeirFoulds LLP (included in Exhibit 5.1).</A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify">24.1</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="#poa_001">Powers of Attorney (included on the signature page of this Registration Statement)</A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify">99.1</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1985062/000121390025057779/ea024690601ex10-1_psyence.htm">Psyence Biomedical Ltd. 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 6-K filed with the SEC on July 25, 2025).</A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify">107*</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: bottom"><A HREF="ea025001801ex-fee_psyence.htm">Filing Fee Table</A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Filed herewith</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.65pt; text-align: justify; text-indent: 35.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.65pt; text-align: justify; text-indent: 35.9pt"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.65pt; text-align: justify; text-indent: 35.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Item 9. Undertakings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being made, a post-effective amendment to this
Registration Statement:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">to include any prospectus required by Section 10(a)(3) of
the Securities Act;</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">to reflect in the prospectus any facts or events arising
after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change
in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration
statement; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">to include any material information with respect to the plan
of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration
Statement; to include any material information with respect to the plan of distribution not previously disclosed in the Registration
Statement or any material change to that information in the Registration Statement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5pt"><I>provided, however,
</I>that paragraphs (a)(l)(i) and (a)(l)(ii) above do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section
15(d) of the Exchange Act that are incorporated by reference in this Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">That, for the purpose of determining any liability under
the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes that, for the
purposes of determining liability under the Securities Act of, each filing of the Registrant&rsquo;s annual report pursuant to Section
13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant
to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be in the initial
<I>bona fide </I>offering thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication of such issue.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B><A NAME="poa_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Pursuant to the
requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Toronto, Ontario, Canada on the 23<SUP>rd</SUP> day of July, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Psyence Biomedical Ltd.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Neil Maresky </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Neil Maresky</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Power of Attorney</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36.3pt">KNOW ALL PERSONS
BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Neil Maresky and Jody Aufrichtig,
each acting alone, as his true and lawful attorneys-in-fact and agents, each with full power of substitution and re-substitution, for
him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments)
to this Registration Statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to
all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents,
or any of them, or their or his substitutes or substitutes, may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">Pursuant to
the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 30%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 48%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 20%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Neil Maresky</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Chief Executive Officer and Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Neil Maresky</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">(Principal Executive Officer)</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Warwick Corden-Lloyd</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Chief Financial Officer</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Warwick Corden-Lloyd</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">(Principal Financial and Accounting Officer)</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Jody Aufrichtig</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Chairman of the Board and Strategic Business Development Officer</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Jody Aufrichtig</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Marc Balkin</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Marc Balkin</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Christopher (Chris) Bull</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Christopher (Chris) Bull</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Seth Feuerstein</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">July 23, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Seth Feuerstein</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>AUTHORIZED U.S. REPRESENTATIVE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Pursuant to the Securities Act of 1933, as amended, the
undersigned, the duly authorized representative in the United States of Psyence Biomedical Ltd. has signed this registration statement
in the city of Newark, Delaware on the 23rd day of July, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Puglisi &amp; Associates</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>Isl</I></FONT> Donald J. Puglisi </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Donald J. Puglisi</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Authorized Representative</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea025001801ex5-1_psyence.htm
<DESCRIPTION>OPINION OF WEIRFOULDS LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barristers
&amp; Solicitors&nbsp;</P></TD>
  <TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 23, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Psyence Biomedical Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">121 Richmond Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Penthouse Suite 1300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Toronto, Ontario, M5H 2K1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mesdames/Messrs:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">Re:</TD><TD>Registration Statement on Form S-8</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as Canadian corporate counsel to
Psyence Biomedical Ltd. (the &ldquo;<B>Corporation</B>&rdquo;), a corporation incorporated under the laws of Ontario, Canada, in connection
with the filing of a registration statement on Form S-8 (the &ldquo;<B>Registration Statement</B>&rdquo;), by the Corporation with the
United States Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) under the U.S. Securities Act of 1933, as amended
(the &ldquo;<B>Securities Act</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of the Registration Statement is to
register the offer and sale of up to 70,174 common shares in the capital of the Corporation (the &ldquo;<B>Common Shares</B>&rdquo;) which
may be issued under the Psyence Biomedical Ltd. 2023 Equity Incentive Plan (as amended from time to time, the &ldquo;<B>Plan</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Examination of Documents</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In giving the opinions expressed below we have
examined:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">a Certificate of Status issued under the <I>Business Corporations Act</I> (Ontario) dated July 23, 2025;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">a copy of the Plan;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Registration Statement;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the certificate of incorporation, articles and by-laws of the Corporation (the &ldquo;<B>Articles</B>&rdquo;);
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">certain resolutions of the Corporation&rsquo;s directors and shareholders.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 8pt">
    <TD ROWSPAN="2" STYLE="border: Black 1pt solid; width: 73%; text-align: center; font-size: 8pt">4100 - 66 Wellington Street West, PO Box 35, TD Bank Tower, Toronto, Ontario, Canada. M5K 1B7</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-top: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 27%; text-align: center; font-size: 8pt; padding-bottom: 2.5pt"><B STYLE="font-size: 8pt">T: 416-365-1110&nbsp;&nbsp;&nbsp;&nbsp;F: 416-365-1876</B></TD></TR>
  <TR STYLE="font-size: 8pt">
    <TD STYLE="padding-top: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 8pt; padding-bottom: 2.5pt">www.weirfoulds.com</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barristers
&amp; Solicitors&nbsp;</P></TD>
  <TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Assumptions and Reliances</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As to certain matters of fact, we have relied
on a certificate of an officer of the Corporation of even date (the &ldquo;<B>Officer&rsquo;s Certificate</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparation for the delivery of this opinion,
we have examined the above-mentioned documents and we have examined all such other documents and made such other investigations as we
consider relevant and necessary in order to give this opinion. In particular, we have not reviewed, and express no opinion on, any document
that is referred to or incorporated by reference into the documents reviewed by us. As to various questions of fact material to this opinion
which we have not independently established, we have examined and relied upon, without independent verification, certificates of public
officials and officers of the Corporation including, without limitation, the Officer&rsquo;s Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this opinion letter, we have also
assumed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">the legal capacity of all individuals;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the genuineness of all signatures on, and the authenticity and completeness of all documents submitted
to us as originals and the conformity to authentic or original documents of all documents submitted to us as certified, conformed, telecopied,
photostatic, electronically transmitted copies (including commercial reproductions);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">the identity and capacity of any person acting or purporting to act as a corporate or public official;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the accuracy and completeness of all information provided to us by public officials or offices of public
record;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">the accuracy and completeness of all representations and statements of fact contained in all documents,
instruments and certificates (including the Officer&rsquo;s Certificate);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">the accuracy and completeness of the minute books and all other corporate records of the Corporation reviewed
by us;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">the facts stated in the Certificate of Status continue to be true as of the date hereof;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">all securities referred to herein have been offered, issued and sold in compliance with applicable United
States federal and state securities laws, and in the manner stated in the Registration Statement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">that the facts stated in the Certificate of Status and the Officer&rsquo;s Certificate shall continue
to be true and correct as at the date of completion of the share issuances contemplated hereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barristers
&amp; Solicitors&nbsp;</P></TD>
  <TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not undertaken any independent investigation
to verify the accuracy of any of the foregoing assumptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When our opinion refers to Common Shares to be
issued or having been issued as being &ldquo;fully paid and non-assessable&rdquo;, such opinion indicates that the holder of such Common
Shares cannot be required to contribute any further amounts to the Corporation by virtue of his, her or its status as holder of such Common
Shares, either in order to complete payment for the Common Shares, to satisfy claims of creditors or otherwise. We rely on the Corporation&rsquo;s
confirmation that it has received, or will receive prior to issuance, full consideration for the Common Shares and no opinion is expressed
as to the adequacy of any consideration received for such Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are qualified to practice law only in the Province
of Ontario. Our opinion below is limited to the existing laws of the Province of Ontario and the federal laws of Canada applicable therein
as of the date of this opinion and should not be relied upon, nor are they given, in respect of the laws of any other jurisdiction. In
particular, we express no opinion as to United States federal or state securities laws or any other laws, rule or regulation, federal
or state, applicable to the Corporation. We disclaim any obligation or duty to update this opinion to reflect any changes in such laws
or other circumstances after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinions given below are given as of the date
of this letter and are not prospective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Opinion</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon and subject to the foregoing, we are
of the opinion that, provided that all necessary corporate action has been taken by the Corporation to authorize the issuance of the Share
Options (as defined in the Plan), Share Appreciation Rights (as defined in the Plan), Restricted Shares (as defined in the Plan), Restricted
Share Units (as defined in the Plan), or Other Share-Based Awards (as defined in the Plan) (collectively, the &ldquo;<B>Awards</B>&rdquo;)
which may be issued under the Plan, we are of the opinion that upon the redemption, settlement or exercise of the Awards, as applicable,
in accordance with their terms, the Plan and any applicable Award Agreement (as defined in the Plan), the Common Shares underlying the
Awards will be validly issued, fully paid and non-assessable shares in the capital of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is rendered as of the date
hereof, and is opining upon and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable therein, as
such laws presently exist as of the date hereof. We express no opinion with respect to the effect or applicability of the laws of any
other jurisdiction. We assume no obligation to revise or supplement this opinion letter should applicable laws be changed after the date
hereof by legislative action, judicial decision or otherwise, or if we become aware of any facts that might change the opinions expressed
herein after the date hereof. The opinions expressed in this letter are limited to the matters set forth herein and no other opinions
should be inferred beyond the matters expressly stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the filing of this opinion as an
exhibit to the Registration Statement and to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the prospectus
constituting part of the Registration Statement. In giving this consent, we do not thereby imply or admit that we are an &ldquo;expert&rdquo;
within the meaning of Section 11 of the Securities Act or the rules and regulations promulgated thereunder or that we come within the
categories of persons whose consent is required by Section 7 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ <I>WeirFoulds LLP</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea025001801ex23-1_psyence.htm
<DESCRIPTION>CONSENT OF MNP LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex23-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 17.9pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 17.9pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consent to the incorporation by
reference in the Registration Statement on Form S-8, of our auditor&rsquo;s report dated June 25, 2025 relating to the consolidated financial
statements of Psyence Biomedical Ltd. and its subsidiaries (the &ldquo;Company&rdquo;) as at March 31, 2025 and 2024 and for each of
the years in the three- year period ended March 31, 2025, as included in the Annual Report on Form 20-F of the Company for the year ended
March 31, 2025, as filed with the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    MNP LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">MNP LLP</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chartered
    Professional Accountants</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed
    Public Accountants</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 23,
    2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Toronto,
Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="ex23-1_001.jpg" ALT=""></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea025001801ex-fee_psyence.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Psyence
Biomedical Ltd</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table
1: Newly Registered Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">Security Type</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">Security Class Title</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Fee Calculation &nbsp;Rule</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Amount Registered(1)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Proposed Maximum Offering Price Per Share</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Maximum Aggregate Offering&nbsp;Price</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Fee Rate</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Amount of Registration Fee</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 12%; vertical-align: top">Equity</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 27%; text-align: center">Common stock, no par value, that may be issued under the Psyence Biomedical Ltd. 2023 Equity Incentive Plan </TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; width: 7%; text-align: center">457(h)</TD><TD STYLE="vertical-align: middle; width: 1%; text-align: right"></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">70,174</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">5.28</TD><TD STYLE="width: 1%; text-align: left">(2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">370,518.72</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">0.00015310</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">56.73</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="10" STYLE="vertical-align: top; text-align: left">Total Offering Amounts</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">370,518.72</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">56.73</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="14" STYLE="padding-bottom: 1.5pt; text-align: left">Total Fee Offsets</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="10" STYLE="padding-bottom: 4pt; text-align: left">Net Fee Due</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left"></TD><TD STYLE="padding-bottom: 4pt; text-align: right"></TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">56.73</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule
    416(a) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this registration statement shall also cover
    any additional shares of common stock, no par value per share, of the Registrant (the &ldquo;Common Stock&rdquo;) that may become
    issuable under the Psyence Biomedical Ltd. 2023 Equity Incentive Plan as a result of any stock dividend, stock split, recapitalization
    or other similar transaction which results in an increase in the number of shares of the Registrant&rsquo;s outstanding Common Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely
    for the purpose of calculating the registration fee pursuant to Rules 457(h) and 457(c) under the Securities Act, based upon the
    average of the high and low prices of the Common Stock, as reported on the Nasdaq Stock Market on July 18, 2025, which date is within
    five business days prior to the filing of this registration statement. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  > .,# 2(  A$! Q$!_\0
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M#87%QG5PTZ,ZV&KK$4OW?HK\@/\ @BG\</B]^TC^Q/>^._C7\0O$/CWQI/\
M%CQYX=3Q/JTMI_:MKI%EHWA5[*UMI;>UBB1;.>^O+FV,D,I2:=LYB"1)^;__
M  5*^+'[3'[$/[0'[+O@3X0?M;_M%:MX>^*WF7OBNW^(/BGPOXBE9[/QCI6E
M)#82V'@S0Q;VTMG>2QW$,J7(D(C(*CS%?IP?!.*QG$^8\)K,L%2S+ 5<=352
M='&SPF)_L_#2Q6)G"K3CSTDJ:2IQK4N:I*22Y4FSAS3Q8R_+. ,D\1Y9%FN(
MR+.*&4UW1IXK*J>8X'^VL?#+L#3K8>M4]GB9.O)RK2PN(4*-.+;]HY1B?T$_
MM1?!/X8?%GX<>(]4^(/A=/$%_P"!_!?CG4_"MT=7U_29='OYM!EGDNH&T/5=
M-\R7SM.LI$:Y\_R7MU:$(2Y;\-_^#;GQEXO\8_#O]J>?Q;XI\1^*)K+QE\,8
MK.7Q#K>IZR]I%+I'C1I4MCJ5U<FW65DC,HBV&7RXA(6$4>W^ASXN?\DH^)W_
M &3WQI_ZC>I5_,[_ ,&XOBK1? OP)_;7\;>)+K[%X?\ "&J^!_%&NWFW<;71
M] \+>/\ 5=2N A*[FBL[6:0)N!8J%&"17KY"ZN(\-^-Z3<ZSHYEPK3PE.7[Q
MT7B,=6YX8=24G2=>K*'/&DX>UFX\RF['S?&,</@_'/PEQ,52PJQ.1^(=?,JT
M/W"Q,<%E&&]G6QTH2A&NL)0A4]G/$1J_5Z49^S=.*E?^J2OY0_\ @OO\,/!W
M[-G@O]GSQ)\";;6_ACKGCGQU\0H?%NH>&?&7C.WEUV&VTWPY?6\=ZEQX@N("
MD%Y>W4T2QQ1[&N)57",5KV+]A'XG?M(?\%;OC'\</BY\0OCI\8/@?^S1\+-=
MTO0O 'PB^!GC&Y^&]WJFIZJVJ7NG6GB;Q=H4(UK5GT;0[:VO?$L[WHFU+5]6
ML$TI](T:"33I/E'_ (.!/!GQ3^%OA;]G#P#XC\=^)?BW\+Y_%/CWQ!\/_&_C
M^YL;[XC^&=073O#=GXB\ ^)]<TZRT]/&.F*LVE:WX5\2:G91>(88)]7T75[S
M5UL+&^;W>!\@J\/^(.3Y1B\UPT\?%^US;**4,2\/'GRS$XF.$JXFHG@<=BL+
M&O1JU:$:+A";FJ%:K4I33^/\6N,L-QIX+\3\39=P[CJ6337U?ASB7$U< L94
M]EG^!P-3,L/@*$HYOE.79C+"8G#X?&3Q2JUJ?LWB\+AJ&)IM?U7? *:>X^!/
MP5N+F::YN9_A+\.)KBXN99+BXGGE\':,\LT\\K/+--+(S/++*[R2.S.[,S$G
MUJOSZ^*W[1,O[*7_  3>M/C[9Z5;:WJW@']GGX9W/A_2;YIET^]\2ZUX?\*^
M'?#J:DUN5G.F0ZSJ]E<ZDD$D,\MA!<10313/'(OS-^RW\#]<_;#_ &9?A]^T
M/J'[>'[3]S\7_B7X8C\2ZEXD^%OQ6MO#7@'X;>,M0C>XOO NG_"+1M,A\&C3
MO!=_(-#U/2/$%C<:SJ8LKB9]4LA>P/;_ )X\C=:ACLYQ>*CE^6+/<3E5/$?4
M\7C7/&N6)Q<X.E@^1T:%'#N$IU:E1.4I*CAZ->I&:A^V+BV.%Q>4<+Y;EU3.
M<_EPC@.(ZV"69Y=E4:65QA@,NIU(XG,_:+$XO$XV-2%+#4*,E3IPEB<=BL)0
MJ4I5?V>HK\A/@_\ %?\ :P\/_P#!.O\ :9\5_&'XC7US^T;^S=??M*:):>/V
M\(>%K9/$%Q\$+;4Y_#FH7&BWF@-HFKZ#XB.F1RR:A'I\5]J&DW@DAU**^ O!
M]R?L<^-/&?Q-_95_9_\ B;\0?$<WB7QM\3/A#X ^(/B35CI>B:- FL>,O"NE
MZ]?6FFZ9H>G:?86NF6-U?2P:=%+#<W8MDC%[>7DV^9O'S' SR[&8K!RKT,2\
M+B)8?ZQAI2GAZZ4*=6%:A.<(2E2JTJU.<'*,9VE:48RC)+ZC),VIYWE679K3
MPN,P,<QP<,6L'CZ<*6-PC=2O1JX7%TZ=2K3AB*%?#5Z56-.I4IW@I0G*$X2?
MTO17YS_L4?&+XN_%'XT_MP^$?B-X_O/%?A_]G_X^#X3> +&7P[X,T9ET%_"N
MA^)1J.LW?AWP[I-WJ6MI/J$UD)O.M[ V@RVG&Z(G3)_:)^,?Q>\*_MZ?LD_
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M\,:3X'OO&=UKNNZM)90V3C4KGP]8_P!FF\MOM4<U\EW8?JKIW_!/[X;^$OV
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M=>N[S1=0UGX:K)?)J6ERZ)X;O;V&>WOO# NM.@O--,5VSQ174EDI=UJ^$O\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !@ X0# 2(  A$! Q$!_\0
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M:A\4_BA%JGB2YDU_7])AA\/QVGGOH]Z%+EZM_+\OZ[6/M#X1?\%:_AS\0/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!&8EYZC.?3H01C!!&!DGIDGJ2,B@Q*<9S@'=CC
M!/0Y&.01@$=P,=VS\V_M6:?\6]5^#&K6OP<3Q/?>(4\1^"KOQ/H?@'Q#I'@_
MXD^+/A=:>+-(N/BIX2^%_B_Q!?Z1H_A7XB^)? <6NZ7X2URZ\0>#Y;+4KN%=
M)\>?#[6Y=.\<^'O+_@G\:_A#H6E_!/P+\(;_ .*?C3P]\4OB%\1_!ES/\8/B
M#\6/%WQ-^%OB[P/X,U3QCXG\(?$/_A?NI^(OB_8Z[IMQH[:?/X1\6ZM#J&A/
MJ4-Q9 :')I\3 'W$(E'=C@$9+'/.<\]1VZ8Z#WR>6OO^./3'7&>N6Z]2<\8
M_.;Q=^U5J>J/JOB;P!X)U*3X@^&O!7[=ECX1T/Q-\4M;\/\ PQU74?V6?B[9
M_"_4;SQCI6@Z!KL-]/XEN]$'B'PWJK^'-4U/PO8S:CH$%P!K5]J*<W=?M^^*
MO!?PX^##_$3P%\*(?C3X_P#@?'^T#XE\(VW[0&G^$?!MI\.+:VTD,_A/QA\0
MO /AR[\1_$SQ7?:F(?"GPR'A^UT"WOK34[/Q+\5='TFUT_7M9 /T_9=RE22
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MQ%X/\975S96NN>-?A?J7AZZ\27%_X[FU7QAK?O.@_M(^(OBM\5?V/;)X]?\
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M3-(UVQV#R?BAXJT?P[I'B;XKP"]U.#P_XKN6\":?J6I6'@ZTU34@1^A%%%%
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M9XFO[:RL+2XUS5[Y[#3M/L'AL[?TVB@&[A1110(**** "BBB@ HHHH ****
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MCE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\
MX+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")
M%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8_
M_!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#
MF\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO
M_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_P
ML?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%
M_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C
M_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV
M'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?
M\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=
M51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+
M_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\
M$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\
MZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?
M]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+
M_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;
M_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_
M^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_
MCE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\
MX+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")
M%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8_
M_!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#
MF\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO
M_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_P
ML?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%
M_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C
M_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV
M'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?
M\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=
M51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+
M_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\
M$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\
MZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?
M]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+
M_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;
M_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_CE_\ZJOV'HH#F\H_
M^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\ X+K?]&Q?\$XO_$B_
MCE_\ZJOV'HH#F\H_^ _\$_'C_A8__!=;_HV+_@G%_P")%_'+_P"=51_PL?\
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M;83)\JVN.R=[-Z:ZKIU^[\3](?'7_!6'_@FE\,/''BKX:?$7]N7]F;P3X_\
M WB+4_"/C/PCXF^*_A;2-=\+^)M%O)=/U?0]=L;R_BDTW4-,OH9K6]@NO+-O
M-$Z2E2IKW#7?VS?V3/#?P);]I_6/VCO@Q;_LZ)<:1:'XWP?$+PSJ'PP-UKVK
MV.@:-;+XRTW4;O1&GU'6M3T_3+6);LO)>7MM" &F0'^-']F?7_\ @F_\,O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_!-/]H?]E;_@L%XD_;'_ &=-(^'^J_LF?$3]CWP_\'_'7@?4O'MSX>^(,_Q
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<GVLEY'8BVMIKA)+IH/M-Q<RR^]44 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  (,# 2(  A$! Q$!_\0
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M:SIGB/1=(\0Z+=QW^CZ]I=AK.DWT.3#>Z9JEI%?6%W$2 3'<VL\4R9 .UQD
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MX=_$7PK\2=>O;Z]2&UT;0_$G@75+.[U>_5XD2RL8K;X;7TLM[)<.DD=C.#%
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M-R7MV5M+2:6+^,W]A#]JW6_V,_VA=.^-FCS7ACMO /Q6\):EIUFJL=83Q?\
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M'B<OR_&2C/&8'!8N<(\D)XK"8;$2A!OF<8RKT*LHQ<O><8M)RU:;U/DKX_\
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J*5.C1IQY:=*C3A2I4XIMJ,*=.,(0BG)OEC"*NV[7;;****#0**** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
